Cingulate logo

Cingulate Share Price Today

(NASDAQ: CING)

Cingulate share price is $3.76 & ₹327.00 as on 6 Mar 2025, 2.30 'hrs' IST

$3.76

-0.09

(-2.34%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Cingulate share price in Dollar and Rupees. Guide to invest in Cingulate stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cingulate, along with analyst recommendations, forecasts, and comprehensive financials.

Cingulate share price movements

  • Today's Low: $3.60
    Today's High: $3.86

    Day's Volatility :6.74%

  • 52 Weeks Low: $1.80
    52 Weeks High: $20.83

    52 Weeks Volatility :91.36%

Cingulate (CING) Returns

PeriodCingulate IncIndex (Russel 2000)
3 Months
-9.62%
0.0%
6 Months
-37.54%
0.0%
1 Year
-72.27%
0.0%
3 Years
-98.75%
-11.6%

Cingulate (CING) Key Statistics

in dollars & INR

Previous Close
$3.85
Open
$3.79
Today's High
$3.86
Today's Low
$3.6
Market Capitalization
$12.1M
Today's Volume
$127.5K
52 Week High
$20.83
52 Week Low
$1.8001
Revenue TTM
$0.0
EBITDA
$-15.6M
Earnings Per Share (EPS)
$-43.22
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-273.82%

How to invest in Cingulate Stock (CING) from India?

It is very easy for Indian residents to invest directly in Cingulate from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cingulate stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cingulate or CING on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cingulate or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cingulate shares which would translate to 0.231 fractional shares of Cingulate as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cingulate, in just a few clicks!

Returns in Cingulate (CING) for Indian investors in Rupees

The Cingulate stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cingulate investment value today

Current value as on today

₹32,677

Returns

₹67,323

(-67.32%)

Returns from Cingulate Stock

₹72,271 (-72.27%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Cingulate (CING)

-25%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Cingulate Stock from India on INDmoney has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Cingulate

  • Commonwealth Equity Services Inc

    1.34%

  • Geode Capital Management, LLC

    0.85%

  • UBS Group AG

    0.38%

  • AlphaMark Advisors, LLC

    0.16%

  • Bank of America Corp

    0.06%

  • Tower Research Capital LLC

    0.02%

Analyst Recommendation on Cingulate

Buy

    70%Buy

    30%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Cingulate(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Cingulate Stock (CING)

What analysts predicted

Upside of 841.49%

Target:

$35.40

Current:

$3.76

Insights on Cingulate Stock (Ticker Symbol: CING)

  • Price Movement

    In the last 7 days, CING stock has moved down by -10.9%
  • CING vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 138.8%
  • CING vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 150.4%

Cingulate Technicals Summary

Sell

Neutral

Buy

Cingulate is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Cingulate (CING) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cingulate Inc logo
-17.54%
-37.54%
-72.27%
-98.75%
-99.65%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cingulate Inc logo
NA
NA
NA
-9.98
-2.74
-1.04
NA
3.95
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cingulate Inc logo
Buy
$12.1M
-99.65%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Cingulate

Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas.
Organization
Cingulate
Employees
13
CEO
Dr. Shane J. Schaffer Pharm.D.
Industry
Miscellaneous

Management People of Cingulate

NameTitle
Dr. Shane J. Schaffer Pharm.D.
CEO & Chairman of the Board
Dr. Laurie A. Myers M.B.A., Ph.D.
Executive VP & COO
Dr. Matthew N. Brams M.D.
Executive VP & Chief Medical Officer
Ms. Jennifer L. Callahan CPA
Senior VP, CFO & Secretary
Dr. Raul R. Silva M.D.
Executive VP & Chief Science Officer
Thomas Dalton
Vice President of Investor & Public Relations

Important FAQs about investing in CING Stock from India :

What is Cingulate share price today?

Cingulate share price today stands at $3.76, Open: $3.79 ; Previous Close: $3.85 ; High: $3.86 ; Low: $3.60 ; 52 Week High: $20.83 ; 52 Week Low: $1.80.

The stock opens at $3.79, after a previous close of $3.85. The stock reached a daily high of $3.86 and a low of $3.60, with a 52-week high of $20.83 and a 52-week low of $1.80.

Can Indians buy Cingulate shares?

Yes, Indians can invest in the Cingulate (CING) from India.

With INDmoney, you can buy Cingulate at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Cingulate at zero transaction cost.

How can I buy Cingulate shares from India?

It is very easy to buy Cingulate from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cingulate (CING) be purchased?

Yes, you can buy fractional shares of Cingulate with INDmoney app.

What are the documents required to start investing in Cingulate stocks?

To start investing in Cingulate, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Cingulate Stock (CING)?

Today’s highest price of Cingulate (CING) is $3.86.

Today’s lowest price of Cingulate (CING) is $3.60.

What is today's market capitalisation of Cingulate?

Today's market capitalisation of Cingulate CING is 12.1M

What is the 52 Week High and Low Range of Cingulate Stock (CING)?

  • 52 Week High

    $20.83

  • 52 Week Low

    $1.80

What are the historical returns of Cingulate (CING)?

  • 1 Month Returns

    -17.54%

  • 3 Months Returns

    -37.54%

  • 1 Year Returns

    -72.27%

  • 5 Years Returns

    -99.65%

Who is the Chief Executive Officer (CEO) of Cingulate ?

Dr. Shane J. Schaffer Pharm.D. is the current Chief Executive Officer (CEO) of Cingulate.